In the 1970s, a dozen scientists entered the tomb of Casimir IV in Poland. Within weeks, 10 of them died from Aspergillus ...

Three years after the Dobbs decision, the legal challenges continue for activists on both sides of the abortion debate.

AstraZeneca AZN announced that the FDA has expanded the label of its cancer drug Datroway for a second indication — non-small ...

Brain metastases are common in ROS1-positive NSCLC, particularly after disease progression. Among 56% with measurable brain ...

CSL's R&D chief says the company's new hereditary angioedema treatment is one of only a few drugs to be built from scratch in ...

FDA’s public guidance continues to warn that, “under most circumstances,” importing drugs for personal use is unlawful, ...

The debate over the Biosimilar Red Tape Elimination Act raises critical concerns about FDA standards, physician trust, and ...

Penn-led researchers have engineered a powerful cancer-fighting compound from Aspergillus flavus, a toxic fungus linked to ...

The breakup comes due to Novo Nordisk’s claims that Hims & Hers has ‘failed to adhere to the law’ by continuing to sell ...

Pharmacoequity requires policies geared at equitable access to the right medicine for all individuals — regardless of race, ethnicity or socioeconomic status. This should be our north star.

Exelixis stock shines with 36% CABOMETYX sales growth, promising zanzalintinib market expansions, and raised 2025 guidance.